1. India Stocks

  2. •

    Health services

  3. •

    Medical/Nursing services
Lotus Eye Hospital And Institute Ltd

Lotus Eye Hospital And Institute Ltd

112.75
INR
+1.70
(+1.53%)
0.07EPS
1,559.19P/E
2.39BMarket Cap
Lotus Eye Hospital And Institute Ltd
BSE:LOTUSEYE
(Bombay Stock Exchange)

Recent

price

112.75

P/E

ratio

1,559.19

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
9.2
12.61
14
13.8
14.38
14.97
15.86
16.96
18.16
19.23
15.23
18.31
22.11
22.72
23.37
25.23
28.24
Revenue per Share
0.21
-1.08
0.2
0.02
-0.95
0.05
0.21
0.84
0.34
0.51
0.75
1.44
1.96
1.4
0.36
0.04
0.07
Basic EPS, GAAP
- -
-0.53
1.11
-0.44
-1.5
1.07
0.72
0.72
-0.24
1.23
1.08
-0.13
0.62
0.02
-1.02
-4.82
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
0.6
0.6
- -
- -
0.5
0.5
0.49
0.01
0.01
- -
Dividend per Share
25.56
24.48
24.68
24.7
23.75
23.8
24.07
24.35
24.1
24.65
25.34
26.26
27.69
28.57
28.85
28.92
- -
Book Value per Share
25.56
24.45
24.62
24.66
23.72
23.59
23.97
24.24
24
24.54
25.26
26.2
27.64
28.53
28.79
28.81
- -
Tangible Book Value per Share
21
21
21
21
21
21
21
21
21
21
21
21
21
21
21
21
20
Basic Weighted Avg Shares
191
262
291
287
299
311
335
353
378
400
317
381
460
472
486
525
573
Sales/Revenue/Turnover
4.08
-8.79
0.91
-0.57
-6.1
-1.33
0.73
3.92
1.12
4.42
4.16
9.1
10.25
6.15
1.14
-0.37
0.5
Operating Margin (%)
26
40
37
35
47
44
34
34
31
25
23
25
30
37
30
37
46
Depreciation Expense
4
-23
4
- -
-20
1
4
17
7
11
16
30
41
29
7
1
1
Net Income, GAAP
22.4
- -
8.67
60.92
- -
- -
- -
- -
- -
26.86
21.29
27.09
27.86
27.39
46.53
- -
34.17
Effective Tax Rate (%)
2.27
-8.59
1.43
0.14
-6.63
0.32
1.32
4.95
1.87
2.66
4.95
7.84
8.87
6.17
1.52
0.15
0.26
Profit Margin (%)
51
-8
24
-1
-11
10
26
11
10
47
78
71
95
77
41
20
- -
Working Capital
2
3
1
- -
7
5
3
1
1
4
1
7
2
7
20
130
- -
LT Debt
532
509
513
514
494
495
501
506
501
513
527
546
576
594
600
601
- -
Total Equity
- -
- -
0.47
-0.13
- -
- -
- -
- -
- -
1.44
2.1
4.6
5.98
3.57
0.49
- -
- -
Return on Invested Capital (%)
- -
- -
0.84
0.08
- -
- -
- -
- -
- -
2.16
3.07
5.65
7.27
5.03
1.5
- -
- -
Return on Capital (%)
- -
-4.33
0.81
0.08
-3.93
0.2
0.89
3.47
1.41
2.1
3.02
5.56
7.27
4.98
1.24
0.13
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
28
- -
LT Borrowings
- -
102
- -
LT Finance Leases
- -
28
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
21
21
21
Market Capitalization
2,465
2,108
2,387

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
114
- -
Cash, Cash Equivalents & STI
- -
37
- -
Accounts Receivable, Net
- -
12
- -
Inventories
- -
38
- -
Total Current Liabilities
- -
93
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
28
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.98%
2.69%
0.23%
Free Cash Flow
-658.22%
-1,158.07%
371.16%
Net Income, GAAP
60.68%
-13.06%
-89.12%
Sales/Revenue/Turnover
5.96%
10.92%
7.97%
Total Cash Common Dividend
- -
- -
9.35%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
129
129
122
115
486
2026
135
130
135
136
525
2027
171
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.3
0.05
-0.11
0.12
0.36
2026
0.26
0.06
-0.13
-0.15
0.04
2027
0.3
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
0.01
2027
- -
- -
- -
- -
- -
Similar Companies
Hims & Hers Health, Inc. (NYSE:HIMS)
Mobile-health Network Solutions (NASDAQ:MNDR)
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)
Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
Tenon Medical, Inc. (NASDAQ:TNON)
Teladoc Health, Inc. (NYSE:TDOC)
Business
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) operates as a specialty eye care provider offering comprehensive ophthalmology services, including cataract surgery, glaucoma treatment, retinal disorders management, corneal transplants, oculoplasty, pediatric ophthalmology, and refractive surgery such as LASIK; it also provides diagnostic services like optical coherence tomography, fundus photography, and visual field testing, along with pharmacy and optical dispensing. The company serves patients across urban and rural segments in India, with a network of hospitals and clinics primarily concentrated in southern and eastern regions including Tamil Nadu, Andhra Pradesh, Telangana, and West Bengal. Founded in 1999 and headquartered in Coimbatore, India, Lotus Eye maintains a focus on affordable, high-volume eye care delivery through its super-specialty facilities and community outreach programs. In recent developments, the company expanded its capacity with the launch of a new super-specialty eye hospital in Bhubaneshwar in 2023 and reported robust financial growth in fiscal year 2025, driven by increased surgical volumes and strategic investments in advanced equipment; it also strengthened its market position through tie-ups with insurance providers for broader accessibility.